Skip to content

Bio-Path Holdings, Inc.: 10-Q filed 2014-08-14

What Bio-Path Holdings, Inc. reported in its quarterly report filed 2014-08-14 (fiscal Q2 2014): 20 published measures, 64 facts as tagged in accession 0001144204-14-050058.

This filing

Form
10-Q (quarterly report)
Filed
2014-08-14
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-050058 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Bio-Path Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-3017,365,242USD
At 2013-12-315,078,831USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-30333,519USD
At 2013-12-31294,898USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-3017,031,723USD
At 2013-12-314,783,933USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-1,268,777USD91
2014-01-01 to 2014-06-30-1,773,654USD181
2007-05-10 to 2014-06-30-17,170,951USD2609
2013-04-01 to 2013-06-30-427,244USD91
2013-01-01 to 2013-06-30-1,083,246USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2014-04-01 to 2014-06-300USD91
2014-01-01 to 2014-06-300USD181
2007-05-10 to 2014-06-300USD2609
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-01-01 to 2014-06-30209,071USD181
2007-05-10 to 2014-06-303,927,304USD2609
2013-01-01 to 2013-06-3029,557USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-1,274,801USD91
2014-01-01 to 2014-06-30-1,785,012USD181
2007-05-10 to 2014-06-30-17,502,932USD2609
2013-04-01 to 2013-06-30-428,646USD91
2013-01-01 to 2013-06-30-1,084,556USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-3016,034,036USD
At 2013-12-313,667,313USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-30333,519USD
At 2013-12-31294,898USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-06-3078,915USD
At 2013-12-3176,109USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,274,801USD91
2014-01-01 to 2014-06-301,785,012USD181
2007-05-10 to 2014-06-3017,502,932USD2609
2013-04-01 to 2013-06-30428,646USD91
2013-01-01 to 2013-06-301,084,556USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-30517,040USD91
2014-01-01 to 2014-06-30624,681USD181
2007-05-10 to 2014-06-306,469,166USD2609
2013-04-01 to 2013-06-30156,036USD91
2013-01-01 to 2013-06-30557,135USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-3089,237,872shares
At 2013-12-3184,237,872shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-3034,113,436USD
At 2013-12-3120,096,991USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-06-301,331,206USD
At 2013-12-311,411,518USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-06-30149,341USD
At 2013-12-3166,739USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-30754,548USD91
2014-01-01 to 2014-06-301,135,400USD181
2007-05-10 to 2014-06-309,829,509USD2609
2013-04-01 to 2013-06-30240,543USD91
2013-01-01 to 2013-06-30480,354USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-04-01 to 2014-06-306,024USD91
2014-01-01 to 2014-06-3011,358USD181
2007-05-10 to 2014-06-30331,981USD2609
2013-04-01 to 2013-06-301,402USD91
2013-01-01 to 2013-06-301,310USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2014-01-01 to 2014-06-3013,812,373USD181
2007-05-10 to 2014-06-3027,182,704USD2609
2013-01-01 to 2013-06-302,515,961USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-3089,981USD181
2007-05-10 to 2014-06-30141,345USD2609
2013-01-01 to 2013-06-3084,180USD181

Inspect the source

Entity
Bio-Path Holdings, Inc. / CIK 0001133818
Captured
2026-09-20T07:41:23.212Z
SEC response SHA-256
ba1a5b94a703d7df40927e88576df9dbcb07b38680ce9a942065f8bd6fea9eee

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001133818.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))